PRKAA2 and early-onset autosomal dominant Alzheimer disease: Emerging evidence indicates a role for AMPK in the neuroendocrine control of organismal metabolism with aging and food intake [36–38], even in the pathogenesis of several neurodegenerative disorders, such as Alzheimer’s disease and amyotrophic lateral sclerosis [39, 40].